A low molecular weight heparin (LMW-heparin) with a mean molecular weight of 4900 dalton was prepared by controlled enzymatic depolymerization of conventional porcine mucosal heparin. The effects of 2,500, 5,000 and 10,000 U (XaI; 29, 58 and 116 mg) on factor Xa inhibition (XaI), factor IIa inhibition (IIaI), APTT, AT III and platelet count were compared to those of 5,000 U (XaI; 26 mg) of conventional heparin given s.c. to 6 healthy volunteers. 5,000 U (XaI; 58 mg) of LMW-heparin was given i.v. A dose related response with regard to the XaI and the IIa-inhibitory activities with peak values at 4 hours after the s.c. injections was obtained. An increase of the XaI/IIaI ratio over the time after injection was seen only after i.v. administrat...
Introduction. For a long time, the main medication for treating and preventing of thrombotic complic...
Differences in the structure of three low molecular weight heparins (LMWHs) have been observed by ap...
We investigated whether the inactivation of factor IXa contributes to the partial inhibition of thro...
Abstract. Porcine mucosal heparin was chemically depolymerized. The depolymerization was stopped at ...
Despite the well-established medical use of heparins, the question arises whether the efficacy-safet...
Unfractionated heparin (UFH) is mostly obtained from porcine and bovine mucosa and has been widely u...
Three fractions of the low molecular weight heparin CY2l6 (fraxiparin, mean molecular weight [MMW] 5...
Low molecular weight (LMW) heparin preparations have unknown distributions of ATIII-binding material...
Anticoagulant therapy with heparin has been the cornerstone of treatment and prevention of thrombosi...
unfractionated (UF) and low molecular weight (tMW) heparins have been measured in human plasma and w...
Heparins with different structures and physico-chemical properties were evaluated for their capacity...
Rabbit being a common animal modei to evaluate the antithrombot-ic effect of heparins, our pulpose w...
The effect of various well-characterized heparin preparations on the inactivation of human Factor XI...
Native heparin (CAS 9005-49-6) and its two new fragments, low molecular weight heparin (LMW-H, 5 kDa...
Heparin and heparin related drugs have remained the anticoagulant of choice for medical and surgical...
Introduction. For a long time, the main medication for treating and preventing of thrombotic complic...
Differences in the structure of three low molecular weight heparins (LMWHs) have been observed by ap...
We investigated whether the inactivation of factor IXa contributes to the partial inhibition of thro...
Abstract. Porcine mucosal heparin was chemically depolymerized. The depolymerization was stopped at ...
Despite the well-established medical use of heparins, the question arises whether the efficacy-safet...
Unfractionated heparin (UFH) is mostly obtained from porcine and bovine mucosa and has been widely u...
Three fractions of the low molecular weight heparin CY2l6 (fraxiparin, mean molecular weight [MMW] 5...
Low molecular weight (LMW) heparin preparations have unknown distributions of ATIII-binding material...
Anticoagulant therapy with heparin has been the cornerstone of treatment and prevention of thrombosi...
unfractionated (UF) and low molecular weight (tMW) heparins have been measured in human plasma and w...
Heparins with different structures and physico-chemical properties were evaluated for their capacity...
Rabbit being a common animal modei to evaluate the antithrombot-ic effect of heparins, our pulpose w...
The effect of various well-characterized heparin preparations on the inactivation of human Factor XI...
Native heparin (CAS 9005-49-6) and its two new fragments, low molecular weight heparin (LMW-H, 5 kDa...
Heparin and heparin related drugs have remained the anticoagulant of choice for medical and surgical...
Introduction. For a long time, the main medication for treating and preventing of thrombotic complic...
Differences in the structure of three low molecular weight heparins (LMWHs) have been observed by ap...
We investigated whether the inactivation of factor IXa contributes to the partial inhibition of thro...